Company Overview of Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule therapeutics to treat metabolic and inflammatory diseases. The company is developing a pipeline of treatments for diabetes and arthritis. The company was formerly known as Galileo Laboratories, Inc. and changed its name to Galileo Pharmaceuticals, Inc. in April, 2003. The company was founded in 1997 and is headquartered in Santa Clara, California.
5301 Patrick Henry Drive
Santa Clara, CA 95054
Founded in 1997
Key Executives for Galileo Pharmaceuticals, Inc.
Similar Private Companies By Industry
|Life Plus International||United States|
|Zand Herbal Formulas||United States|
|ClinicAid Research Management, Inc.||United States|
|Synomics Pharmaceutical Services, LLC||United States|
|Takeda America Holdings, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- New York City, NY | InformaticaPosted: Feb 20
- Fredericksburg, VA | AstellasPosted: Mar 07
- Parsippany, NJ | RGPPosted: Mar 05
- San Francisco, CA | PwCPosted: Apr 12
Sponsored Financial Commentaries
To contact Galileo Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.